Search

It has been approved for use in individuals 2 years or older who have iron overload caused by blood transfusion and for individuals 10 years or older with chronic iron overload syndrome. Compare to: Jadenu Camber Pharmaceuticals has added deferasirox tablets, the generic equivalent of Jadenu, to its lineup. Deferasirox is used to treat iron overload caused by blood transfusions and chronic iron overload syndrome caused by a genetic blood disorder. [Extracted from the article]

The article reports on the new prescribing information launched by the U.S. Food and Drug (FDA) and Novartis Oncology for deferasirox after discovering that the drug may cause renal, hepatic and gastrointestinal damage.

The article discusses research on the effectiveness of deferasirox in decreasing labile plasma iron in patients beta-thalassemia, that references a study by S. Daar published in a 2009 issue of The "European Journal of Hematology."